Pathology of myxomatous mitral valve disease in the dog.
Fox PR.
J Vet Cardiol. 2012 Mar;14(1):103-26. doi: 10.1016/j.jvc.2012.02.001. Epub 2012 Mar 3.
Mitral Valve Pathology.
Fishbein GA, Fishbein MC.
Curr Cardiol Rep. 2019 May 23;21(7):61. doi: 10.1007/s11886-019-1145-5.
Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-beta mechanisms.
Oyama MA, Elliott C, Loughran KA, Kossar AP, Castillero E, Levy RJ, Ferrari G.
Cardiovasc Pathol. 2020 May-Jun;46:107196. doi: 10.1016/j.carpath.2019.107196. Epub 2020 Jan 7.
Transcatheter Mitral Valve-in-Valve Therapy.
Condado JF, Kaebnick B, Babaliaros V.
Interv Cardiol Clin. 2016 Jan;5(1):117-123. doi: 10.1016/j.iccl.2015.08.011. Epub 2015 Oct 17.
Signaling pathways in mitral valve degeneration.
Orton EC, Lacerda CM, MacLea HB.
J Vet Cardiol. 2012 Mar;14(1):7-17. doi: 10.1016/j.jvc.2011.12.001. Epub 2012 Feb 23.
Mitral valve prolapse.
Wigle ED, Rakowski H, Ranganathan N, Silver MC.
Annu Rev Med. 1976;27:165-80. doi: 10.1146/annurev.me.27.020176.001121.
The mechanobiology of mitral valve function, degeneration, and repair.
Richards JM, Farrar EJ, Kornreich BG, Moїse NS, Butcher JT.
J Vet Cardiol. 2012 Mar;14(1):47-58. doi: 10.1016/j.jvc.2012.01.002. Epub 2012 Feb 25.
Structural valve degeneration in the transcatheter mitral valve implantation era.
Narayan P.
J Card Surg. 2021 Nov;36(11):4431-4433. doi: 10.1111/jocs.15911. Epub 2021 Aug 9.
Transcatheter mitral valve replacement.
Enta Y, Nakamura M.
J Cardiol. 2021 Jun;77(6):555-564. doi: 10.1016/j.jjcc.2020.10.020. Epub 2020 Nov 25.
Postsurgical Transcatheter Mitral Valve Replacement.
Kargoli F, Al Qaraghuli AK, Fang HK, Eng MH.
Interv Cardiol Clin. 2024 Apr;13(2):207-216. doi: 10.1016/j.iccl.2023.12.002. Epub 2024 Jan 9.
